SOLVENTUM CORP
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 5,035 | 49.9 |
| Stockholders' equity | 5,049 | 50.1 |
| Total capitalization | 10,084 | 100.0 |
170,223,729 shares outstanding at 31 July 2026 (cover page of the 10-Q filed 5 August 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 5,035 |
| Long-term debt, noncurrent | 5,035 |
| Current maturities | 0 |
| Short-term borrowings / commercial paper | 0 |
CAPITAL STOCK 12/31/25
| Common shares authorized | 750,000,000 |
| Common shares issued | 173,490,864 |
| Par or stated value per share ($) | 0.01 |
| Outstanding at 7/31/26 | 170,223,729 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | – | – |
| 2024 | – | – |
| 2023 | – | – |
| 2022 | – | – |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware. Formerly known as 3M Health Care Co (to 9 February 2024).
BUSINESS: Classified by the SEC under Standard Industrial Classification 3841, Surgical & Medical Instruments & Apparatus. Large accelerated filer. Principal executive office: 1750 Yankee Doodle Road, Eagan, MN 55121. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Revenues | 8,325 | 8,254 | 8,197 |
| Gross profit | 4,451 | 4,593 | 4,693 |
| Research and development | 739 | 775 | 758 |
| Selling, general and administrative | 3,080 | 2,782 | 2,299 |
| Depreciation and amortization | 489 | 555 | 561 |
| Operating income | 2,181 | 1,036 | 1,692 |
| Income before income taxes | 1,713 | 605 | 1,667 |
| Income taxes | 157 | 127 | 321 |
| Net income | 1,556 | 479 | 1,346 |
| Earned per share, diluted ($) | 8.88 | 2.76 | 7.79 |
| Dividends per share ($) | – | – | – |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Cash and equivalents | 878 | 762 |
| Receivables, net | 1,034 | 1,044 |
| Inventories | 1,066 | 965 |
| Total current assets | 3,859 | 3,249 |
| Property, plant and equipment, net | 1,326 | 1,622 |
| Goodwill | 5,704 | 6,377 |
| Total assets | 14,294 | 14,457 |
| Total current liabilities | 3,136 | 2,703 |
| Long-term debt | 5,035 | 7,810 |
| Total liabilities | 9,245 | 11,498 |
| Stockholders' equity | 5,049 | 2,959 |
| Total liabilities and equity | 14,294 | 14,457 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 8,325 | 2,181 | 1,556 | 18.7 | 8.88 | – | 369 | 379 | (10) | 14,294 | 9,245 | 5,035 | 5,049 | 30.8 | 1.00 |
| 12/31/24 | 8,254 | 1,036 | 479 | 5.8 | 2.76 | – | 1,185 | 380 | 805 | 14,457 | 11,498 | 8,010 | 2,959 | 16.2 | 2.71 |
| 12/31/23 | 8,197 | 1,692 | 1,346 | 16.4 | 7.79 | – | 1,915 | 290 | 1,625 | 13,943 | 2,277 | 0 | 11,666 | 11.5 | 0.00 |
| 12/31/22 | 8,130 | 1,693 | 1,343 | 16.5 | 7.78 | – | 1,679 | 251 | 1,428 | – | – | – | 11,742 | 11.4 | – |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
Solventum Corp
CIK 1964738 · EIN 92-2008841
PRINCIPAL OFFICE:
1750 Yankee Doodle Road, Eagan, MN 55121
Tel.: 651-733-1110
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
3841 · Surgical & Medical Instruments & Apparatus
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 27 February 2026
FORMER NAMES:
3M Health Care Co
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/27/26) · 10-K FY2024 (filed 2/28/25). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.